NITD-564
CAS No. 1614262-75-7
NITD-564( NITD564 )
Catalog No. M12348 CAS No. 1614262-75-7
NITD-564 is a novel, direct inhibitor of the mycobacterial enoyl-reductase InhA with IC50 of 0.59 uM, exhibits MIC50 of 160 nM against Mtb.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNITD-564
-
NoteResearch use only, not for human use.
-
Brief DescriptionNITD-564 is a novel, direct inhibitor of the mycobacterial enoyl-reductase InhA with IC50 of 0.59 uM, exhibits MIC50 of 160 nM against Mtb.
-
DescriptionNITD-564 is a novel, direct inhibitor of the mycobacterial enoyl-reductase InhA with IC50 of 0.59 uM, exhibits MIC50 of 160 nM against Mtb; binds specifically to InhA in an NADH-dependent manner and blocks the enoyl substrate-binding pocket; shows in vivo efficacy in acute and established mouse models of Mycobacterium tuberculosis infection.
-
In Vitro——
-
In Vivo——
-
SynonymsNITD564
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1614262-75-7
-
Formula Weight283.371
-
Molecular FormulaC18H21NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name6-(cyclohexylmethyl)-4-hydroxy-3-phenylpyridin-2(1H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Manjunatha UH, et al. Sci Transl Med. 2015 Jan 7;7(269):269ra3.
molnova catalog
related products
-
Nacubactam
Nacubactam is a potent inhibitor of non-β-lactam-β-lactamase with activity against class A and class C β-lactamases.
-
Allergen Gal d 4 (46...
Allergen Gal d 4 (46-61), chicken is a hen egg white lysozyme peptide.
-
PBP 10
Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.
Cart
sales@molnova.com